October 2021- Volume 17, Issue 10

In this Issue

Editor's Focus

Antimicrobial resistance: The silent pandemic

Antimicrobial resistance: The silent pandemic

Antimicrobial resistance: The silent pandemic

Scientists continue to ring alarm bells about the risks associated with the continued misuse of antimicrobials and advocate for innovative treatments, improved surveillance, and greater public health education.
Targeting gut bacteria to treat autism

Targeting gut bacteria to treat autism

Targeting gut bacteria to treat autism

Scientists leverage the gut microbiome-brain connection to develop new treatments for autism spectrum disorders.

Editors Insight

The black swan

The black swan

The black swan

How can scientists bridge the communication gap between themselves and the public?

Microbiology

Understanding bacteriophages

Understanding bacteriophages

Understanding bacteriophages

Ultra-microscopic viruses that selectively target and kill bacteria may mitigate antimicrobial resistance.

Cell Biology

Harnessing cells' own RNA editing tools for new therapeutics 

Harnessing cells' own RNA editing tools for new therapeutics 

Harnessing cells' own RNA editing tools for new therapeutics 

By redirecting cells’ endogenous RNA editing machinery, scientists can correct disease-causing mutations, bringing a new kind of gene therapy to the clinic.
Special report: Live and let die

Special report: Live and let die

Special report: Live and let die

Researchers redefine cell death in disease and drug discovery.
Decoding cell behavior and disease with AI and single-cell transcriptomics

Decoding cell behavior and disease with AI and single-cell transcriptomics

Decoding cell behavior and disease with AI and single-cell transcriptomics

Machine learning paired with single-cell analysis helps scientists identify pathways that cause disease and potential therapeutics.

Rare Diseases

CRISPR-based muscular dystrophy therapy

CRISPR-based muscular dystrophy therapy

CRISPR-based muscular dystrophy therapy

An engineer turned biology researcher co-founded a bio-pharma start-up with the goal of using CRISPR to reverse the mutation causing the degenerative muscle disorder Duchenne muscular dystrophy.
CRISPR editing for treating Duchenne muscular dystrophy

CRISPR editing for treating Duchenne muscular dystrophy

CRISPR editing for treating Duchenne muscular dystrophy

Researchers are using CRISPR gene editing to restore function of the mutant protein that causes Duchenne muscular dystrophy, a genetic disease that causes muscle degeneration.
Genetic studies of rare undiagnosed diseases take flight with model organisms

Genetic studies of rare undiagnosed diseases take flight with model organisms

Genetic studies of rare undiagnosed diseases take flight with model organisms

Researchers use fruit flies to figure out how genetic mutations disrupt biology and how drugs might reverse these effects.
Subscribe to our eNewsletters

Stay connected with all of the latest from Drug Discovery News.

Latest Issue's Magazine Cover

Latest Issue  

• Volume 17 • Issue 10 • October 2021

October 2021

October 2021 Issue